发明名称 AMINOINDANE DERIVATIVE OR SALT THEREOF
摘要 Provided is a compound that is an NMDA receptor antagonist having a broader safety margin, and is useful as an agent for treating or preventing Alzheimer's disease, cerebrovascular dementia, Parkinson's disease, ischemic apoplexy, or pain. A novel compound or salt thereof represented by formula I (see formula I) which is characterized in that is has an amino group and R1 (lower alkyl, cycloalkyl, -lower alkylene-aryl, aryl which may be substituted, and the like) on carbon atoms of indane, cyclopenta[b]thiophene, cyclopenta[b]furan, cyclopenta[b]pyridine, or cyclopenta[c]pyridine ring, or a 2,3-dihyro-1-benzofuran, 2,3-dihydro-1-benzothiophene or indoline ring, or the like, and has R2 and R3 (the same or different, each lower alkyl or aryl) on carbon atoms beside them, and an NMDA receptor antagonist comprising the same as an active ingredient.
申请公布号 CA2657106(C) 申请公布日期 2011.09.20
申请号 CA20072657106 申请日期 2007.07.17
申请人 ASTELLAS PHARMA INC. 发明人 HAYASHIBE, SATOSHI;YAMASAKI, SHINGO;WATANABE, KAZUSHI;SHIRAISHI, NOBUYUKI;SUZUKI, DAISUKE;HOSHII, HIROAKI;OHMORI, JUNYA;KANAYAMA, TAKATOSHI
分类号 C07C211/42;A61K31/13;A61K31/381;A61K31/404;A61K31/435;A61K31/4453;A61P25/00;A61P25/04;A61P25/16;A61P25/28;A61P43/00;C07C215/42;C07C215/44;C07C217/52;C07C255/58;C07D209/40;C07D221/16;C07D295/12;C07D307/82;C07D333/78 主分类号 C07C211/42
代理机构 代理人
主权项
地址